Transcatheter arterial chemoembolization for gastrointestinal stromal tumors with liver metastases

Table 2 Univariate analysis by each variable

Variable	n	OS (wk)	P value
Gender			0.133
Male	45	34.3
Female	15	25.7
Primary tumor location			0.825
Stomach	24	25.7
Intestine	25	34.3
Others	11	30.0
ECOG PS			0.102
0-1	36	35.8
2	24	24.5
Number of liver metastases			0.079
1	16	42.9
2-5	29	25.7
> 5	15	38.6
Extrahepatic metastases			0.005
Yes	26	25.7
No	34	42.9
TKI reintroduction			0.657
Yes	34	30.0
No	26	30.0
TACE treatment			0.0001
Yes	22	68.5
No	38	25.7

OS: Overall survival; ECOG PS: The Eastern Cooperative Oncology Group performance status; TKI: Tyrosine kinase inhibitors; TACE: Transcatheter arterial chemoembolization.